Physician profile
Robert P Mathis
NPI 1447230271
$1,372.49
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $51.62 · 2021: $377.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $706.02 | 2019 | |
| W. L. Gore & Associates, INC. | $336.25 | 2019-2021 | |
| Penumbra, INC. | $142.47 | 2019-2021 | |
| Medtronic, INC. | $65.50 | 2021 | |
| Getinge USA Sales, LLC | $26.60 | 2021 | |
| Covidien LP | $21.11 | 2019 | |
| Convatec INC. | $16.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.71 | 2020 | |
| Cook Medical LLC | $14.00 | 2020 | |
| Medtronic USA, INC. | $13.54 | 2019 | |
| Boston Scientific Corporation | $13.44 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.